Valiant Organics

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE565V01010
  • NSEID: VALIANTORG
  • BSEID: 540145
INR
269.05
8.55 (3.28%)
BSENSE

Mar 20

BSE+NSE Vol: 4.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

4.55 lacs (-39.29%) Volume

Shareholding (Dec 2025)

FII

0.23%

Held by 13 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

37.89%

Who are the top shareholders of the Valiant Organics?

06-Jun-2025

The top shareholders of Valiant Organics include promoter Jaya Chandrakant Gogri with 8.25% and public shareholder Nikhil Parimal Desai with 9.17%. Individual investors hold 37.41%, while 17 foreign institutional investors hold a combined 0.37%, with no pledged promoter holdings or mutual fund investments.

The top shareholders of Valiant Organics include Jaya Chandrakant Gogri, who is the promoter with the highest holding at 8.25%. Additionally, the highest public shareholder is Nikhil Parimal Desai, holding 9.17%. Individual investors collectively hold a significant portion of the company at 37.41%. There are also 17 foreign institutional investors (FIIs) that hold a combined 0.37% of the shares. Notably, there are no pledged promoter holdings and no mutual funds currently invested in the company.

View full answer

how big is Valiant Organics?

06-Jun-2025

As of Jun 06, Valiant Organics Ltd has a market capitalization of 1,210.64 Cr, with net sales of 718.77 Cr and a net profit of -3.74 Cr for the latest four quarters. Shareholder's Funds are 729.29 Cr and Total Assets are 1,247.96 Cr as of Mar'24.

Market Cap: As of Jun 06, Valiant Organics Ltd has a market capitalization of 1,210.64 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Valiant Organics reported net sales of 718.77 Cr and a net profit of -3.74 Cr. This data is on a Consolidated basis.<BR><BR>Balance Sheet Snapshot: The balance sheet data is also on a Consolidated basis for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 729.29 Cr, while Total Assets amount to 1,247.96 Cr.

View full answer

What is the bonus history of the Valiant Organics?

06-Jun-2025

Valiant Organics issued a 1:1 bonus share on December 24, 2020, with a record date of December 28, 2020, effectively doubling shareholders' holdings.

Valiant Organics has a bonus history that includes a notable 1:1 bonus issue announced with an ex-date of December 24, 2020. The record date for this bonus was December 28, 2020. This means that for every share held, shareholders received an additional share, effectively doubling their holdings at that time. If you have any more questions about Valiant Organics or need further details, feel free to ask!

View full answer

Has Valiant Organics declared dividend?

06-Jun-2025

Valiant Organics Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of February 10, 2023. However, the company has shown significant variability in total returns, with negative returns in longer periods and a dividend yield of 0%.

Valiant Organics Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1 per share<BR>- Ex-date: 10 Feb 23<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 27.24%, the dividend return was 0%, resulting in a total return of 27.24%.<BR><BR>Over the past year, the price return was 10.57%, with a dividend return of 0%, leading to a total return of 10.57%.<BR><BR>In the 2-year period, the price return was -29.27%, the dividend return was 0%, resulting in a total return of -29.27%.<BR><BR>For the 3-year period, the price return was -34.02%, with a dividend return of 0.86%, culminating in a total return of -33.16%.<BR><BR>In the 4-year period, the price return was -72.23%, the dividend return was 0.30%, resulting in a total return of -71.93%.<BR><BR>Over the last 5 years, the price return was -35.84%, with a dividend return of 1.14%, leading to a total return of -34.7%.<BR><BR>Overall, while Valiant Organics has declared a dividend, the total returns over various periods show significant variability, with some periods reflecting negative returns, particularly in the longer term. The absence of a consistent dividend yield further indicates challenges in maintaining shareholder value.

View full answer

Who are the peers of the Valiant Organics?

16-Jul-2025

Valiant Organics' peers include Jyoti Resins, Platinum Industries, Oriental Aromatics, Fairchem Organic, Amal, Indo Amines, Indokem, Nitta Gelatin, and Jayant Agro Org. In terms of management risk, growth ratings, and capital structure, Valiant Organics shows average performance, with a 1-year return of 5.17%, significantly lower than Indokem's 278.31%.

Peers: The peers of Valiant Organics are Jyoti Resins, Platinum Industr, Oriental Aromat., Fairchem Organic, Amal, Indo Amines, Indokem, Nitta Gelatin, and Jayant Agro Org.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jyoti Resins, Platinum Industr, Amal, Nitta Gelatin, and Jayant Agro Org., while Average management risk is found at Oriental Aromat., Fairchem Organic, Indo Amines, and Valiant Organics, and Below Average management risk is noted at Indokem. Growth ratings show Excellent growth at Jyoti Resins and Amal, Good growth at Indo Amines and Jayant Agro Org., Average growth at Platinum Industr and Nitta Gelatin, Below Average growth at Oriental Aromat. and Fairchem Organic, and Valiant Organics shows Below Average growth. Capital Structure is Excellent at Platinum Industr and Fairchem Organic, Good at Valiant Organics and Jayant Agro Org., Average at Amal, Below Average at Indo Amines, and Indokem, and Good at Nitta Gelatin.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Indokem at 278.31%, while Fairchem Organic has the lowest at -29.77%. Valiant Organics has a 1-year return of 5.17%, which is higher than Fairchem Organic but significantly lower than Indokem. Additionally, Fairchem Organic and Indokem have negative six-month returns.

View full answer

Who are in the management team of Valiant Organics?

16-Jul-2025

As of March 2022, the management team of Valiant Organics includes Chairman Navin Chapshi Shah, Managing Director Arvind Chheda, and several executive and independent directors, totaling twelve key members who guide the company's governance and strategy.

As of March 2022, the management team of Valiant Organics includes the following individuals:<BR><BR>1. Navin Chapshi Shah - Chairman & Independent Director<BR>2. Arvind Chheda - Executive Director / Managing Director / Chief Financial Officer / Promoter<BR>3. Mahek Manoj Chheda - Executive Director & Wholetime Director<BR>4. Nemin Mahesh Savadia - Executive Director<BR>5. Sathiababu Krishnan Kallada - Non-Executive & Non-Independent Director<BR>6. Siddharth D. Shah - Executive Director<BR>7. Vishnu Sawant - Executive Director & Wholetime Director<BR>8. Kiritkumar Haribhai Desai - Non-Executive & Non-Independent Director<BR>9. Santosh S. Vora - Non-Executive Director<BR>10. Mulesh Manilal Savla - Independent Non-Executive Director<BR>11. Sonal A Vira - Independent Director<BR>12. Sudhirprakash Baburao Sawant - Independent Director<BR><BR>This diverse team encompasses various roles, including executive, independent, and non-executive positions, contributing to the governance and strategic direction of the company.

View full answer

What does Valiant Organics do?

17-Jul-2025

Valiant Organics Ltd is a specialty chemical manufacturer in the Agro Intermediate and Pharma sectors, with a market cap of INR 1,148 Cr. As of March 2025, it reported net sales of 2,038 Cr and a net profit of 42 Cr.

Overview: <BR>Valiant Organics Ltd is a specialty chemical manufacturer operating in the Agro Intermediate and Pharma sectors, categorized as a Small Cap company.<BR><BR>History: <BR>Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' in 2005. It transitioned to a Public Limited Company in 2015. The most recent quarterly results reported net sales and net profit for March 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 2,038 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: 42 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: INR 1,148 Cr (Small Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 37 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.33 <BR>Return on Equity: -0.52% <BR>Price to Book: 1.56<BR><BR>Contact Details: <BR>Address: 109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080 <BR>Tel: 91-22-25913767/3766/67976640/5 <BR>Email: investor@valiantorganics.com <BR>Website: http://www.valiantorganics.com

View full answer

How has been the historical performance of Valiant Organics?

15-Nov-2025

Valiant Organics has faced significant fluctuations in financial performance, with net sales declining from 1,051.80 Cr in March 2023 to 718.76 Cr in March 2025, while profitability metrics have also decreased, resulting in a negative profit after tax of -2.67 Cr in March 2025. Despite a slight recovery in operating profit, the overall financial environment remains challenging.

Answer:<BR>The historical performance of Valiant Organics has shown significant fluctuations over the years, particularly in net sales and profitability.<BR><BR>Breakdown:<BR>Valiant Organics reported net sales of 718.76 Cr in March 2025, a slight decline from 723.06 Cr in March 2024 and a notable decrease from 1,051.80 Cr in March 2023. The total operating income mirrored this trend, falling to 718.76 Cr in March 2025 from 723.06 Cr in the previous year and down from 1,051.80 Cr in March 2023. The raw material costs also decreased to 440.07 Cr in March 2025 from 483.40 Cr in March 2024, contributing to a total expenditure of 665.09 Cr in March 2025, which was lower than 684.81 Cr in March 2024. Operating profit (PBDIT) rose to 62.31 Cr in March 2025 from 47.55 Cr in March 2024, but this was significantly lower than the 172.26 Cr reported in March 2023. The profit before tax showed a recovery to 2.91 Cr in March 2025 from a loss of 7.13 Cr in March 2024, yet it was down from 137.18 Cr in March 2023. The profit after tax remained negative at -2.67 Cr in March 2025, although it improved from -6.84 Cr in March 2024. The consolidated net profit also reflected this trend, standing at -3.74 Cr in March 2025 compared to -8.39 Cr in March 2024 and a profit of 88.12 Cr in March 2023. Total assets decreased to 1,182.93 Cr in March 2025 from 1,247.96 Cr in March 2024, while total liabilities also fell to 1,182.93 Cr from 1,247.96 Cr. Cash flow from operating activities was 56.00 Cr in March 2025, down from 84.00 Cr in March 2024, indicating a decline in cash generation capabilities. Overall, Valiant Organics has experienced a challenging financial environment with fluctuating sales and profitability metrics over the past few years.

View full answer

Is Valiant Organics overvalued or undervalued?

28-Nov-2025

As of November 27, 2025, Valiant Organics is considered overvalued with a PE ratio of 30.94 and an EV to EBITDA of 11.73, especially when compared to peers like Cipla and Sun Pharma, and has underperformed the Sensex with a year-to-date return of -14.77%.

As of 27 November 2025, Valiant Organics has moved from a very attractive to an attractive valuation grade. The company appears to be overvalued based on its current metrics. The PE ratio stands at 30.94, while the EV to EBITDA is 11.73 and the PEG ratio is notably low at 0.18, indicating potential overvaluation compared to growth expectations.<BR><BR>In comparison to its peers, Valiant Organics' valuation seems less favorable. For instance, Sun Pharma has a PE ratio of 37.62 and an EV to EBITDA of 24.87, categorizing it as expensive, while Cipla, also rated attractive, has a PE of 22.67 and an EV to EBITDA of 16.04. Furthermore, Valiant's recent stock performance has lagged significantly behind the Sensex, with a year-to-date return of -14.77% compared to the Sensex's 9.70%, reinforcing the notion that it may be overvalued in the current market context.

View full answer

Is Valiant Organics technically bullish or bearish?

02-Dec-2025

As of December 1, 2025, the trend is mildly bearish due to bearish momentum from the weekly MACD and Bollinger Bands, although monthly indicators suggest potential for recovery.

As of 1 December 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and Bollinger Bands indicating bearish momentum. The daily moving averages also reflect a bearish outlook. However, the monthly MACD and KST show mildly bullish signals, suggesting some potential for recovery over a longer time frame. Overall, the lack of strong bullish signals and the prevailing bearish indicators indicate a cautious approach is warranted.

View full answer

When is the next results date for Valiant Organics Ltd?

10-Feb-2026

The next results date for Valiant Organics Ltd is 13 February 2026.

The next results date for Valiant Organics Ltd is scheduled for 13 February 2026.

View full answer

Are Valiant Organics Ltd latest results good or bad?

13-Feb-2026

Valiant Organics Ltd's latest results show a year-over-year profit increase of 144.37%, indicating recovery, but a significant quarter-on-quarter decline in profit (30.85%) and sales (23.04%) raises concerns about short-term performance and sustainability. Overall, the results are mixed, reflecting both recovery and potential challenges ahead.

Valiant Organics Ltd's latest results reflect a mixed performance. On one hand, the company reported a net profit of ₹5.67 crores for Q2 FY26, which is a significant improvement of 144.37% year-over-year, indicating a return to profitability compared to the same quarter last year. However, this profit represents a sharp decline of 30.85% compared to the previous quarter, which raises concerns about its short-term performance.<BR><BR>In terms of net sales, the company experienced a notable decline of 23.04% quarter-on-quarter, bringing sales down to ₹157.31 crores. This figure also reflects a slight decrease of 1.79% year-over-year, suggesting ongoing challenges in maintaining consistent revenue growth.<BR><BR>While the operating margin improved to 13.45%, up from 12.15% in the previous quarter, this improvement is overshadowed by the significant drop in sales and profit. The overall outlook indicates that while there are signs of recovery compared to last year, the recent quarterly performance raises questions about the company's ability to sustain growth and profitability in the near term. <BR><BR>In summary, the results can be seen as good in the context of year-over-year recovery, but the quarter-on-quarter declines in both sales and profit signal potential challenges ahead.

View full answer

Should I buy, sell or hold Valiant Organics Ltd?

15-Feb-2026

Why is Valiant Organics Ltd falling/rising?

16-Mar-2026

As of 16-Mar, Valiant Organics Ltd's stock price is Rs. 205.05, reflecting a 1.2% decline and a total drop of 5.7% over the last four days. The stock has significantly underperformed the market, reaching a 52-week low of Rs. 200, and is trading below its moving averages, indicating bearish sentiment.

As of 16-Mar, Valiant Organics Ltd's stock price is falling, currently at Rs. 205.05, which reflects a decrease of Rs. 2.5 or 1.2%. The stock has been on a downward trend, having lost value for the last four consecutive days, resulting in a total decline of 5.7% during this period. Additionally, the stock reached a new 52-week low of Rs. 200 today, indicating significant downward pressure.<BR><BR>In terms of performance relative to the broader market, Valiant Organics has underperformed significantly over various time frames. Over the past week, the stock has decreased by 1.98%, while the Sensex has fallen by 2.66%. Over the past month, the stock has dropped 16.83%, compared to a 9.34% decline in the Sensex. Year-to-date, the stock is down 25.23%, while the Sensex has only decreased by 11.40%. This trend continues over longer periods, with the stock down 47.13% over three years and 84.12% over five years, contrasting sharply with the Sensex's gains.<BR><BR>Moreover, Valiant Organics is trading below its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically indicates a bearish sentiment among investors. Despite a rise in delivery volume by 58.61% on March 13, suggesting increased investor participation, the overall market sentiment and the stock's recent performance suggest a continued decline in its price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Operating profit has grown by an annual rate -22.94% of over the last 5 years

 
2

Flat results in Dec 25

3

Despite the size of the company, domestic mutual funds hold only 0% of the company

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

INR 723 Cr (Micro Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

31

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.31

stock-summary
Return on Equity

3.18%

stock-summary
Price to Book

0.99

Revenue and Profits:
Net Sales:
159 Cr
(Quarterly Results - Dec 2025)
Net Profit:
4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.95%
0%
1.95%
6 Months
-27.52%
0%
-27.52%
1 Year
7.23%
0%
7.23%
2 Years
-32.17%
0%
-32.17%
3 Years
-29.26%
0%
-29.26%
4 Years
-68.8%
0.45%
-68.35%
5 Years
-78.83%
0.32%
-78.51%

Latest dividend: 1 per share ex-dividend date: Feb-10-2023

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Valiant Organics Surges 29.63%: 5 Key Factors Behind the Volatile Week

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Investor Presentation

25-Feb-2026 | Source : BSE

Please find our intimation in captioned subject

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Feb-2026 | Source : BSE

Please find our intimation in captioned subject.

Financial Results For The Quarter Ended December 31 2025.

13-Feb-2026 | Source : BSE

Please find our intimation in captioned subject

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Valiant Organics Ltd has declared 10% dividend, ex-date: 10 Feb 23

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Valiant Organics Ltd has announced 1:1 bonus issue, ex-date: 24 Dec 20

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
1.24%
EBIT Growth (5y)
-22.94%
EBIT to Interest (avg)
10.01
Debt to EBITDA (avg)
3.31
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.97
Tax Ratio
31.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.23%
ROCE (avg)
11.71%
ROE (avg)
9.43%

Valuation key factors

Factor
Value
P/E Ratio
42
Industry P/E
31
Price to Book Value
1.02
EV to EBIT
22.69
EV to EBITDA
12.01
EV to Capital Employed
1.01
EV to Sales
1.36
PEG Ratio
0.21
Dividend Yield
NA
ROCE (Latest)
4.56%
ROE (Latest)
3.18%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 13 FIIs (0.23%)

Promoter with highest holding

Jaya Chandrakant Gogri (8.25%)

Highest Public shareholder

Nikhil Parimal Desai (9.17%)

Individual Investors Holdings

36.55%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -14.77% vs 32.19% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -33.15% vs 169.20% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "159.27",
          "val2": "186.86",
          "chgp": "-14.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.58",
          "val2": "15.33",
          "chgp": "1.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.56",
          "val2": "5.83",
          "chgp": "-21.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.72",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.65",
          "val2": "5.46",
          "chgp": "-33.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.78%",
          "val2": "8.20%",
          "chgp": "1.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 10.25% vs -18.98% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 203.51% vs -180.14% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "361.71",
          "val2": "328.09",
          "chgp": "10.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "45.98",
          "val2": "18.07",
          "chgp": "154.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.22",
          "val2": "13.15",
          "chgp": "-22.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.87",
          "val2": "-13.40",
          "chgp": "203.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "12.71%",
          "val2": "5.51%",
          "chgp": "7.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 1.17% vs -5.74% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 320.65% vs -189.92% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "520.98",
          "val2": "514.95",
          "chgp": "1.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.56",
          "val2": "33.40",
          "chgp": "84.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14.78",
          "val2": "18.98",
          "chgp": "-22.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "5.72",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17.52",
          "val2": "-7.94",
          "chgp": "320.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.82%",
          "val2": "6.49%",
          "chgp": "5.33%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.59% vs -31.25% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 55.42% vs -109.52% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "718.76",
          "val2": "723.06",
          "chgp": "-0.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "53.53",
          "val2": "38.25",
          "chgp": "39.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.64",
          "val2": "16.34",
          "chgp": "44.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-3.41",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.74",
          "val2": "-8.39",
          "chgp": "55.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.45%",
          "val2": "5.29%",
          "chgp": "2.16%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
159.27
186.86
-14.77%
Operating Profit (PBDIT) excl Other Income
15.58
15.33
1.63%
Interest
4.56
5.83
-21.78%
Exceptional Items
5.72
0.00
Consolidate Net Profit
3.65
5.46
-33.15%
Operating Profit Margin (Excl OI)
9.78%
8.20%
1.58%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is -14.77% vs 32.19% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -33.15% vs 169.20% in Dec 2024

Half Yearly Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
361.71
328.09
10.25%
Operating Profit (PBDIT) excl Other Income
45.98
18.07
154.45%
Interest
10.22
13.15
-22.28%
Exceptional Items
0.00
0.00
Consolidate Net Profit
13.87
-13.40
203.51%
Operating Profit Margin (Excl OI)
12.71%
5.51%
7.20%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 10.25% vs -18.98% in Sep 2024

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2025 is 203.51% vs -180.14% in Sep 2024

Nine Monthly Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
520.98
514.95
1.17%
Operating Profit (PBDIT) excl Other Income
61.56
33.40
84.31%
Interest
14.78
18.98
-22.13%
Exceptional Items
5.72
0.00
Consolidate Net Profit
17.52
-7.94
320.65%
Operating Profit Margin (Excl OI)
11.82%
6.49%
5.33%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 1.17% vs -5.74% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2025 is 320.65% vs -189.92% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
718.76
723.06
-0.59%
Operating Profit (PBDIT) excl Other Income
53.53
38.25
39.95%
Interest
23.64
16.34
44.68%
Exceptional Items
0.00
-3.41
100.00%
Consolidate Net Profit
-3.74
-8.39
55.42%
Operating Profit Margin (Excl OI)
7.45%
5.29%
2.16%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -0.59% vs -31.25% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 55.42% vs -109.52% in Mar 2024

stock-summaryCompany CV
About Valiant Organics Ltd stock-summary
stock-summary
Valiant Organics Ltd
Micro Cap
Specialty Chemicals
Valiant Organics Limited was incorporated as 'Valiant Organics Private Limited' on February 06, 2005 in Mumbai, Maharashtra. The status of the Company was changed to a Public Limited Company and the name was changed to 'Valiant Organics Limited' vide fresh Certificate of Incorporation on July 31, 2015 by the Registrar of Companies, Mumbai, and Maharashtra. The Company is a specialty chemical manufacturing for Agro Intermediate and Pharma in India.
Company Coordinates stock-summary
Company Details
109 Udyog Kshetra 1st Floor, Mulund Goregaon Link Rd Mulund Mumbai Maharashtra : 400080
stock-summary
Tel: 91-22-25913767/3766/67976640/5
stock-summary
investor@valiantorganics.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai